Voxelotor: all 26 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Hemolysis Related Complications in SCD. A Phase II Study With VoxelotorRecruitingNCT05199766Phase 2
- Voxelotor CYP and Transporter Cocktail Interaction StudyCompletedNCT05981365Phase 1Results posted
- Resolution of Sickle Cell Leg Ulcers With VoxelotorTerminatedNCT05561140Phase 3Results posted
- Voxelotor for Improving Oxygen Saturation in AdultsTerminatedNCT05289570Phase 2Results posted
- Actigraphy Improvement With Voxelotor (ActIVe) StudyCompletedNCT04400487Phase 4Results posted
- Dose Escalation Study to Evaluate the Safety, Tolerability, PK and PD of Voxelotor in Patients With SCDTerminatedNCT04247594Phase 2Results posted
- Study to Evaluate the Effect of GBT440 on TCD in Pediatrics With Sickle Cell DiseaseTerminatedNCT04218084Phase 3Results posted
- Open-Label Extension of VoxelotorTerminatedNCT04188509Phase 3Results posted
- Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031TerminatedNCT03573882Phase 3Results posted
- An Extension Study to Further Evaluate the Safety, Tolerability of GBT440 in Patients With Sickle Cell Disease Who Participated in the Study GBT440-001CompletedNCT03041909Phase 2Results posted
- Study to Evaluate the Effect of Voxelotor Administered Orally to Patients With Sickle Cell Disease (GBT_HOPE)CompletedNCT03036813Phase 3Results posted
- Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at RestTerminatedNCT02989168Phase 2Results posted
- Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell DiseaseTerminatedNCT02850406Phase 2Results posted
- Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPFCompletedNCT02846324Phase 2Results posted
- Assessing Physical Function in Sickle Cell Patients Taking VoxelotorCompletedNCT06023199Phase 2
- Voxelotor Brain Oxygenation and Neurocognitive StudyWithdrawnNCT05228821Phase 4
- The Effect of Voxelotor on Cerebral Hemodynamic Response in Children With Sickle Cell AnemiaTerminatedNCT05018728Phase 2
- Voxelotor Sickle Cell Exercise StudyCompletedNCT04581356Phase 4
- A Voxelotor for Sickle Cell Anemia Patients at Highest Risk for Progression of Chronic Kidney DiseaseTerminatedNCT04335721Phase 1/2
- Single-Dose PK Study of GBT440 in Subjects With Renal ImpairmentCompletedNCT03161015Phase 1
- Single-Dose PK and Safety Study of GBT440 in Subjects With Hepatic ImpairmentCompletedNCT03114540Phase 1
- Study to Evaluate Effects of Investigational Drug on Oxygenation in Healthy Volunteers Under Hypoxic ConditionsTerminatedNCT03051711Phase 1
- A Single-Dose Relative Bioavailability Study Of GBT440 300 mg Capsules in Healthy SubjectsCompletedNCT02567695Phase 1
- Drug Interaction Study of GBT440 With Caffeine, S-warfarin, Omeprazole, and Midazolam in Healthy SubjectsCompletedNCT02567682Phase 1
- A Study of the Absorption, Metabolism, and Excretion of GBT440 in Healthy Male SubjectsCompletedNCT02497924Phase 1
- A Study of the Safety, Blood Levels and Biological Effects of GBT440 in Healthy Subjects and Subjects With Sickle Cell DiseaseCompletedNCT02285088Phase 1